Vermillion, Inc.
(NASDAQ : VRML)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
TSROTESARO, Inc.
0.37%73.9314.4%$593.48m
AMGNAmgen Inc.
-0.24%189.631.2%$549.98m
GILDGilead Sciences, Inc.
1.75%66.260.9%$544.82m
CELGCelgene Corporation
-0.56%67.751.2%$491.19m
ILMNIllumina, Inc.
0.70%313.053.5%$341.89m
BIIBBiogen Inc.
-4.39%299.361.3%$340.11m
REGNRegeneron Pharmaceuticals, Inc.
0.16%376.102.6%$269.50m
AAgilent Technologies, Inc.
0.77%68.371.5%$216.19m
VRTXVertex Pharmaceuticals Incorporated
1.12%168.031.9%$215.77m
ALXNAlexion Pharmaceuticals, Inc.
0.24%109.792.0%$154.19m
INCYIncyte Corporation
0.77%65.322.5%$97.92m
EXASExact Sciences Corporation
-0.33%66.8925.3%$93.40m
BLUEBluebird Bio, Inc.
-1.93%102.5614.4%$85.84m
SRPTSarepta Therapeutics, Inc.
-0.89%114.6715.4%$83.70m
GBTGlobal Blood Therapeutics Inc
0.47%41.777.0%$81.24m

Company Profile

Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. The company's bio-analytical solutions helps physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion was founded on December 9, 1993 and is headquartered in Austin, TX.